IBDEI1NL ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26402,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,26403,0)
 ;;=E11.641^^107^1241^20
 ;;^UTILITY(U,$J,358.3,26403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26403,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,26403,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,26403,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,26404,0)
 ;;=E11.649^^107^1241^21
 ;;^UTILITY(U,$J,358.3,26404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26404,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,26404,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,26404,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,26405,0)
 ;;=E11.65^^107^1241^17
 ;;^UTILITY(U,$J,358.3,26405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26405,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,26405,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,26405,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,26406,0)
 ;;=E11.69^^107^1241^32
 ;;^UTILITY(U,$J,358.3,26406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26406,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,26406,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,26406,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,26407,0)
 ;;=E11.8^^107^1241^34
 ;;^UTILITY(U,$J,358.3,26407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26407,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,26407,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,26407,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,26408,0)
 ;;=E11.9^^107^1241^35
 ;;^UTILITY(U,$J,358.3,26408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26408,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,26408,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,26408,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,26409,0)
 ;;=E11.29^^107^1241^27
 ;;^UTILITY(U,$J,358.3,26409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26409,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,26409,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,26409,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,26410,0)
 ;;=E11.311^^107^1241^14
 ;;^UTILITY(U,$J,358.3,26410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26410,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,26410,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,26410,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,26411,0)
 ;;=E11.319^^107^1241^15
 ;;^UTILITY(U,$J,358.3,26411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26411,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,26411,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,26411,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,26412,0)
 ;;=E11.3211^^107^1241^22
 ;;^UTILITY(U,$J,358.3,26412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26412,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,26412,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,26412,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,26413,0)
 ;;=E11.3212^^107^1241^23
 ;;^UTILITY(U,$J,358.3,26413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26413,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,26413,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,26413,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,26414,0)
 ;;=E11.3213^^107^1241^24
 ;;^UTILITY(U,$J,358.3,26414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26414,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,26414,1,4,0)
 ;;=4^E11.3213
